Drugs / Meritup
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06151249 | Dec 2023 → Nov 2025 | breast cancer | Chung Shan Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meritup | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06151249 ↗ |
| Route | Oral | “Meritup oral solution” NCT06151249 ↗ |